Literature DB >> 6353671

Amino acid composition of Clostridium botulinum type F neurotoxin.

B E DasGupta, S Rasmussen.   

Abstract

To develop reliable data on the amino acid composition of type F botulinum neurotoxin, three batches of the neurotoxin were analyzed. Each batch was isolated from a separate neurotoxin producing bacterial culture. Two batches had inoculum from one source and the other batch one from a different source. Two batches of the neurotoxin were purified by the same method and one was purified by a different method. The neurotoxin preparations were found comparable in purity and similar in amino acid composition. The best estimate of number of amino acid residues per neurotoxin molecule (mol. wt. 155,000) was: Asp218 Thr80 Ser105 Glu128 Pro47 Gly69 Ala47 Val72 CyS9 Met14 Ile128 Leu104 Tyr86 Phe60 Lys90 His13 Arg51 Trp23.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6353671     DOI: 10.1016/0041-0101(83)90136-8

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.

Authors:  Rakhi Agarwal; Subramanyam Swaminathan
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

Review 2.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  Circular dichroic and fluorescence spectroscopic study of the conformation of botulinum neurotoxin types A and E.

Authors:  A Datta; B R DasGupta
Journal:  Mol Cell Biochem       Date:  1988-02       Impact factor: 3.396

4.  Reductive methylation of lysine residues of botulinum neurotoxin types A and B.

Authors:  V Sathyamoorthy; B R DasGupta
Journal:  Mol Cell Biochem       Date:  1988-09       Impact factor: 3.396

5.  Substrate binding mode and its implication on drug design for botulinum neurotoxin A.

Authors:  Desigan Kumaran; Richa Rawat; S Ashraf Ahmed; Subramanyam Swaminathan
Journal:  PLoS Pathog       Date:  2008-09-26       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.